risedronate sodium (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the risedronate sodium drug offered from Actavis Pharma, Inc.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient],Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: risedronate sodium
SUBSTANCE NAME: RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient],Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2014-06-11
END MARKETING DATE: 0000-00-00


risedronate sodium HUMAN PRESCRIPTION DRUG Details:

Item Descriptionrisedronate sodium from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 129; 21(mg/1; mg/1)
START MARKETING DATE: 2014-06-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0591-2044_7a248a22-542a-4581-8b00-1f87a2febea5
PRODUCT NDC: 0591-2044
APPLICATION NUMBER: NDA020835

Other RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Risedronate Sodium
Allergan, Inc.Actonel
Warner Chilcott (US), LLCAtelvia